首页 › 基金 › RA CAPITAL MANAGEMENT, L.P. › CLYM

RA CAPITAL MANAGEMENT, L.P. 对 CLYM 的持仓历史

CLIMB BIO INC · 医疗保健

RA CAPITAL MANAGEMENT, L.P. 在 Q3 2026 的 13F 申报中披露持有 CLYM(CLIMB BIO INC)10,130,130 股,市值约 US$116.2M,约占其申报组合的 1.20%,在其申报持仓中市值排名第 20 位。 RA CAPITAL MANAGEMENT, L.P. 最近 13 个申报季度中有 13 个季度披露了 CLYM 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q3 2026)10.13M 股
申报持仓市值$116.19M
组合权重1.20%
首次申报Q3 2023
最近变动减持
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

RA CAPITAL MANAGEMENT, L.P. 对 CLYM 的持仓演变

RA CAPITAL MANAGEMENT, L.P. 于 Q3 2023 首次披露 CLYM 持仓:13,150,849 股(约 US$34.6M)。 该持仓在 Q2 2024 达到峰值 31,419,267 股,市值约 US$223.4M。 在 13 次申报中,RA CAPITAL MANAGEMENT, L.P. 1 次增持、2 次减持、9 次保持不变。 最近一期申报(Q3 2026)显示持股 10,130,130 股、市值约 US$116.2M,环比减持 -1,170,809 股。。 持仓曾出现大幅变动:Q2 2024 增持约 139% (随后一个季度股价下跌 28%)、Q4 2025 减持约 64% (随后一个季度股价上涨 71%)。

逐季持仓明细

季度股数金额变化
Q3 2023 13.15M $34.59M 新进
Q4 2023 13.15M $35.51M 持有
Q1 2024 13.15M $36.03M 持有
Q2 2024 31.42M $223.39M 增持
Q3 2024 31.42M $159.92M 持有
Q4 2024 31.42M $56.55M 持有
Q1 2025 31.42M $38.33M 持有
Q2 2025 31.42M $38.96M 持有
Q3 2025 31.42M $63.15M 持有
Q4 2025 11.29M $77.71M 减持
Q1 2026 11.30M $77.41M 持有
Q2 2026 11.30M $147.36M 持有
Q3 2026 10.13M $116.19M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 CLYM 与 13F 数据

CLYM(CLIMB BIO INC)属于医疗保健行业。我们追踪的基金中还有 68 只申报持有 CLYM,申报仓位最大的包括:BRAIDWELL LP (US$32.8M), Cormorant Asset Management, LP (US$24.2M), Redmile Group, LLC (US$11.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 CLYM 的基金

查看 CLYM 的全部基金持有人 →

常见问题

How long has RA CAPITAL MANAGEMENT, L.P. held CLYM?

RA CAPITAL MANAGEMENT, L.P. has disclosed CLYM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is RA CAPITAL MANAGEMENT, L.P.'s current position in CLYM?

As of Q3 2026, RA CAPITAL MANAGEMENT, L.P. holds 10.13M shares of CLYM (CLIMB BIO INC), valued at $116.19M, representing 1.20% of its reported portfolio and ranking #20.

Has RA CAPITAL MANAGEMENT, L.P. been buying or selling CLYM?

In the latest 13F filing (Q3 2026), RA CAPITAL MANAGEMENT, L.P. reduced its position in CLYM. The position peaked in Q2 2024 at 31.42M shares.

Which other funds hold CLYM?

Other major institutional holders of CLYM include BRAIDWELL LP, Cormorant Asset Management, LP, Redmile Group, LLC, among 68 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.